Atlantic Health System

Morristown, New Jersey 07962

12 studies enrolling now · 65 studies all time

What they study most

Adult Disease, Advanced Cancer, Advanced Non-Small Cell Lung Cancer, Advanced Non-Small Cell Non-Squamous Lung Cancer, Advanced Non-Small Cell Squamous Lung Cancer, Advanced Or Metastatic Merkel Cell Carcinoma, Advanced Solid Tumor, Advanced Solid Tumors Appropriate for Treatment With Either Nivolumab or Pembrolizumab, Aortic Stenosis Symptomatic, B Cell Lymphoma, B Cell Non-Hodgkin's Lymphoma, B-cell Malignancies

Studies at this site

• Phase 1 Study of Intratumoral Administration of VAX014 With Expansion in Combination With a Checkpoint Inhibitor in Subjects With Advanced Solid Tumors — Recruiting now
• Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer — Recruiting now
• A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease — Recruiting now
• Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer — Recruiting now
• Letrozole in Uterine Leiomyosarcoma — Recruiting now
• Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors — Recruiting now
• Study of NALIRIFOX in Advanced Unresectable Small Bowel Tumors — Recruiting now
• ELEVATE High-Risk PCI Pivotal Study — Recruiting now
• Pancreatic Cancer Detection Consortium — Recruiting now
• Comparison of Weekly Somatrogon to Daily Genotropin in Children Born Small for Gestational Age or With Idiopathic Short Stature. — Recruiting now
• Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma — Recruiting now
• Fecal Microbiota Transplant National Registry — Recruiting now
• AAV Gene Therapy Clinical Study in Adult Classic PKU (PHEdom) — Recruiting now
• Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA) — Recruiting now
• Ph. 1, Evaluation of Safety, Tolerability, PK, Anti-tumor Activity of STP707 IV in Subjects With Solid Tumors — Completed
• A Study of TRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid Tumors — Running, not enrolling
• A Phase 3 Single-Arm Study of UGN-102 for Treatment of Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer — Running, not enrolling
• In-Home Study With MiniMed™ 780G Pump Automated Control in Type 2-Evaluation of the AHCL System in Adults With Insulin-requiring Type 2 Diabetes — Completed
• Study of Lifileucel (LN-144), Autologous Tumor Infiltrating Lymphocytes, in the Treatment of Patients With Metastatic Melanoma — Completed
• A Study of DF6002 Alone and in Combination With Nivolumab — Completed
• Study of DECOY20 With or Without Tislelizumab in Patients With Advanced Solid Tumors — Running, not enrolling
• Gemcitabine and Cisplatin With or Without CPI-613 as First Line Therapy for Patients With Advanced Unresectable Biliary Tract Cancer (BilT-04) — Stopped early
• Clinical Study of Antibody-Drug Conjugate MYTX-011 in Subjects With Non-Small Cell Lung Cancer — Stopped early
• Siegel™ Transcatheter Aortic Valve Replacement System (TAVR) Early Feasibility Study — Running, not enrolling
• Long-term Extension Study of Zanubrutinib (BGB-3111) Regimens in Participants With B-cell Malignancies — Running, not enrolling
• CardiAMP™ Cell Therapy for Heart Failure Trial — Completed
• A Study of ANV419 Alone or in Combination With Approved Treatment in Patients With Cutaneous Melanoma (OMNIA-1). — Completed
• Enlighten Study: The EV-ICD Post Approval Registry — Running, not enrolling
• Absorbable Suture vs Permanent Suture in Sacrospinous Ligament Suspension — Completed
• A Study of Zanubrutinib (BGB-3111) Versus Ibrutinib in Participants With Relapsed/Refractory Chronic Lymphocytic Leukemia — Completed
• CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy for Relapsed/Refractory B Cell Non-Hodgkin Lymphoma (ANTLER) — Status unconfirmed
• 7-Day Trial of Sucraid for Alleviating CSID Symptoms in Subjects With Low, Moderate, and Normal Sucrase Levels — Stopped early
• Anti-CD137 and Anti-CTLA-4 Monoclonal Antibody in Patients With Advanced Cancer — Completed
• Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 ACUTE — Completed
• Safety, Tolerability, PK, Anti-Tumor Activity of STP705 in Subjects With Advanced/Metastatic or Surgically Unresectable Solid Tumors Who Are Refractory to Standard Therapy — Completed
• A Multicenter, Multinational, Observational Morquio A Registry Study (MARS) — Completed
• Trial of mFOLFOX6 + Trastuzumab + Avelumab in Gastric and Esophageal Adenocarcinomas — Completed
• Study to Compare Adjuvant Immunotherapy of Bempegaldesleukin Combined With Nivolumab Versus Nivolumab After Complete Resection of Melanoma in Patients at High Risk for Recurrence — Stopped early
• Tavo and Pembrolizumab in Patients With Stage III/IV Melanoma Progressing on Either Pembrolizumab or Nivolumab Treatment — Status unconfirmed
• A Study of ADXS-NEO Expressing Personalized Tumor Antigens — Stopped early
• Efficacy/Safety of CPI-613 in Combination With HD Cyt. and Mito. vs HD Cyt. and Mito. in Older Patients With R/R AML — Stopped early
• Efprezimod Alfa (CD24Fc, MK-7110) as a Non-antiviral Immunomodulator in COVID-19 Treatment (MK-7110-007) — Completed
• Study Evaluating Efficacy and Safety of FFX Versus Combination of CPI-613 With mFFX in Patients With Metastatic Adenocarcinoma of the Pancreas — Completed
• Study of Abatacept in the Treatment of Hospitalized COVID-19 Participants With Respiratory Compromise — Stopped early
• A Tissue Collection Study in Patients Who Respond to Immune Checkpoint Inhibitors to Identify Targets of Tumor-Reactive T Cells. — Status unconfirmed
• ACell MatriStem Pelvic Floor Matrix Versus Native Tissue Repair, Comparative Study — Completed
• Restorelle® Mesh Versus Native Tissue Repair for Prolapse — Completed
• PV-10 vs Chemotherapy or Oncolytic Viral Therapy for Treatment of Locally Advanced Cutaneous Melanoma — Stopped early
• Pudendal Block Using Liposomal Bupivacaine vs. Standard Treatment During Sacrospinous Ligament Fixation — Status unconfirmed
• Blood Collection Study From COVID-19 Convalescents Previously Hospitalized to Identify Immunogenic Viral Epitopes — Completed